Moreover, exogenous treatment with recombinant IL-37 exerted anti-inflammatory properties in collagen-induced arthritis (CIA) models, as well as in T cells from patients with rheumatoid arthritis [55]. This evidence concerns the gene IL37 and rheumatoid arthritis.